Premenopausal Endocrine Responsive Chemotherapy Trial

NCT00066807 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

29

Enrollment

NETWORK

Sponsor class

Stopped Poor accrual, patients were followed until completion of 5 yrs treatment

Conditions

Breast Cancer

Interventions

DRUG: chemotherapy
DRUG: exemestane
DRUG: tamoxifen
DRUG: triptorelin
PROCEDURE: oophorectomy
PROCEDURE: ovarian irradiation

Sponsor

ETOP IBCSG Partners Foundation

Collaborators

[object Object]
[object Object]